Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Anesthesiology
    • Cannabis compound may...

    Cannabis compound may be good option to opioids for pain relief

    Written by Medha Baranwal Baranwal Published On 2019-08-09T19:30:19+05:30  |  Updated On 9 Aug 2019 7:30 PM IST
    Cannabis compound may be good option to opioids for pain relief

    Canada: Molecules present in the cannabis plant were found to be 3o times more effective than aspirin at reducing inflammation, according to a new study published in the journal Phytochemistry. Their findings may help provide a solution to the opioid crisis, providing natural pain relief with minimal side effects. Opioids are commonly prescribed drugs for pain relief.


    The compounds are -- Cannflavin A and B -- prenylated flavonoids that are unique to Cannabis sativa. Cannflavins exhibited strong anti-inflammatory properties that can provide pain relief with fewer side effects.


    In addition to the presence of a psychoactive substance, there also exist numerous other specialized metabolites in this plant. Tariq A. Akhtar, University of Guelph, Guelph, Ontario, Canada, and colleagues focused on two such compounds, known as cannflavin A and cannflavin B, and their biosynthesis.


    Also Read: Nabiximols effectively reduce illicit cannabis use in patients with cannabis dependence: JAMA


    "There is a need for the development of alternatives for acute and chronic pain relief, beyond opioids," write the authors. Cannflavins are non-psychoactive and exhibit their action by targeting inflammation at the source, making them the ideal painkillers.


    Cannflavins were first discovered more than 30 years ago, but research into cannabis was highly regulated. Now the drug is legal in Canada, more studies are being carried out looking at how effective it might be in treating health issues.


    Chronic pain sometimes requires treatment with strong opioids which block the brain’s pain receptors. However, the use of opioids carries a significant risk of developing an addiction to drugs.


    Also Read: MRI shows cannabis use leads to changes in brain volume of teenagers


    Relying on cannabis plants to treat pain could provide a useful alternative. The university is proceeding to trying to find a way of extracting the anti-inflammatory properties from the plant. The researchers will also need to test different doses to see how effective the treatment may be.


    To read the complete study follow the link: https://doi.org/10.1016/j.phytochem.2019.05.009

    cannabiscannabis plantCannabis sativaCannflavin A and BCannflavinschronic painflavonoidsinflammationMedical newsopioidsPainPain killerspain managementpain reliefpain treatmentrecent medical newsreducing inflammation

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok